Intellia Therapeutics Inc (NTLA)
21.32
-0.18
(-0.84%)
USD |
NASDAQ |
Apr 18, 16:00
21.18
-0.14
(-0.66%)
Pre-Market: 08:32
Intellia Therapeutics Market Cap: 2.049B for April 18, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 2.049B |
| April 17, 2024 | 2.066B |
| April 16, 2024 | 2.096B |
| April 15, 2024 | 2.203B |
| April 12, 2024 | 2.333B |
| April 11, 2024 | 2.404B |
| April 10, 2024 | 2.398B |
| April 09, 2024 | 2.506B |
| April 08, 2024 | 2.431B |
| April 05, 2024 | 2.382B |
| April 04, 2024 | 2.400B |
| April 03, 2024 | 2.401B |
| April 02, 2024 | 2.412B |
| April 01, 2024 | 2.616B |
| March 28, 2024 | 2.644B |
| March 27, 2024 | 2.597B |
| March 26, 2024 | 2.524B |
| March 25, 2024 | 2.579B |
| March 22, 2024 | 2.586B |
| March 21, 2024 | 2.657B |
| March 20, 2024 | 2.670B |
| March 19, 2024 | 2.655B |
| March 18, 2024 | 2.630B |
| March 15, 2024 | 2.720B |
| March 14, 2024 | 2.645B |
| Date | Value |
|---|---|
| March 13, 2024 | 2.755B |
| March 12, 2024 | 2.670B |
| March 11, 2024 | 2.839B |
| March 08, 2024 | 2.880B |
| March 07, 2024 | 2.885B |
| March 06, 2024 | 2.878B |
| March 05, 2024 | 2.907B |
| March 04, 2024 | 3.113B |
| March 01, 2024 | 3.139B |
| February 29, 2024 | 3.087B |
| February 28, 2024 | 3.152B |
| February 27, 2024 | 2.981B |
| February 26, 2024 | 2.658B |
| February 23, 2024 | 2.508B |
| February 22, 2024 | 2.612B |
| February 21, 2024 | 2.583B |
| February 20, 2024 | 2.609B |
| February 16, 2024 | 2.666B |
| February 15, 2024 | 2.648B |
| February 14, 2024 | 2.630B |
| February 13, 2024 | 2.460B |
| February 12, 2024 | 2.754B |
| February 09, 2024 | 2.625B |
| February 08, 2024 | 2.555B |
| February 07, 2024 | 2.424B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
476.79M
Minimum
Mar 16 2020
12.99B
Maximum
Sep 03 2021
3.608B
Average
3.310B
Median
Market Cap Benchmarks
| Moderna Inc | 39.05B |
| Regeneron Pharmaceuticals Inc | 98.07B |
| NeuroMetrix Inc | 7.251M |
| Repligen Corp | 8.759B |
| Pacific Biosciences of California Inc | 391.21M |
Market Cap Related Metrics
| PS Ratio | 52.54 |
| Price to Book Value | 1.951 |
| Price | 21.32 |
| Earnings Yield | -25.38% |